Live Breaking News & Updates on Fibrogen Inc|Page 10

Stay updated with breaking news from Fibrogen inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Bank of America cut shares of FibroGen from a neutral rating to an underperform rating and cut their price objective for the stock from […] ....

United States , Jacobs Levy Equity Management Inc , Fibrogen Inc , Armistice Capital , Schroder Investment Management Group , Acadian Asset Management , Artisan Partners Limited Partnership , Free Report , Gen Stock Down , Investment Management Group , Asset Management , Levy Equity Management , Get Free Report , Fibrogen Daily , Nasdaq Fgen , Initiated Coverage , Stocknews Com ,

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Adtran (NASDAQ:ADTN), Alpine Immune Sciences (NASDAQ:ALPN)

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. ....

Sanmina Corporation , Unisys Corporation , Singular Genomics Systems Inc , Holdings Inc , Clover Health Investments , Taskus Inc , Evercommerce Inc , Alpine Immune Sciences , Coherus Biosciences Inc , Vimeo Inc , Ameresco Inc , Augmedix Inc , Genetics Inc , Alteryx Inc , Thredup Inc , Rover Group Inc , Fibrogen Inc , Avior Bio , Aura Biosciences Inc , Group Inc , Recovery Inc , Royalty Management Holding Corporation , Hims Hers Health Inc , Datadog Inc , Docgo Inc , Ventyx Biosciences Inc ,

FibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcript

FibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , John Hunter , David Delucia , Paul Choi , Astellas Pharma , Chris Chung , Mark Eisner , William Blair , Randy Shea , Djuan Graham , China Health Authority , Society For Immunotherapy , Goldman Sachs , Pancreatic Cancer Action Network Precision Promise , Fibrogen Inc , Call Transcript November , Third Quarter , Vice President , Investor Relations , Thane Wettig , Chief Executive Officer , Chief Financial Officer , Chief Scientific Officer , Senior Vice President , Thanks Dave , Global Pancreatic Cancer Awareness Month ,

FibroGen Reports Third Quarter 2023 Financial Results

Topline data from two pivotal pamrevlumab pancreatic cancer trials on track to read out in 1H 2024, including the Pancreatic Cancer Action Network (PanCAN) Precision PromiseSM Phase 2/3 study in metastatic pancreatic cancer Third quarter net revenue of $40.1 million, an increase of 155% year over year Roxadustat sNDA accepted in China for chemotherapy-induced anemia Robust roxadustat volume growth of 37% in ChinaStrong execution of cost reduction plan reaffirming cash runway into 2026 SAN FRANCI ....

United States , South Africa , Meichiel Keenan , David Delucia , Society For Immunotherapy Of Cancer Annual Meeting , Corporate Communications , Fibrogen Inc , Exchange Commission , European Society For Medical Oncology Congress , Drug Administration , Pancreatic Cancer Action Network Pancan Precision Promise , China Health Authority , American Society Of Nephrology , Pancreatic Cancer Action Network , Thane Wettig , Chief Executive Officer , Key Events , Third Quarter , Chief Executive , New Drug Application , European Society , Medical Oncology Congress , American Society , Kidney Week , Cancer Annual Meeting , Fibrogen China ,

FibroGen Reports Third Quarter 2023 Financial Results

Topline data from two pivotal pamrevlumab pancreatic cancer trials on track to read out in 1H 2024, including the Pancreatic Cancer Action Network. ....

South Africa , United States , David Delucia , Meichiel Keenan , Exchange Commission , Drug Administration , American Society Of Nephrology , Pancreatic Cancer Action Network Pancan Precision Promise , China Health Authority , European Society For Medical Oncology Congress , Corporate Communications , Society For Immunotherapy Of Cancer Annual Meeting , Fibrogen Inc , Pancreatic Cancer Action Network , Thane Wettig , Chief Executive Officer , Key Events , Third Quarter , Chief Executive , New Drug Application , European Society , Medical Oncology Congress , American Society , Kidney Week , Cancer Annual Meeting , Fibrogen China ,